Arterra Bioscience Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
38
- Stock Symbol
-
ARBS
- Investments
-
3
- Share Price
-
$3.10
- (As of Friday Closing)
Arterra Bioscience General Information
Description
Arterra Bioscience SpA is an Italian biotechnology company developing technologies and solutions for use across various sectors, including cosmetics, pharmaceuticals, agriculture, nutraceuticals, and food, among others. The company has developed cell screening and other technology platforms and offers a range of ingredients and active ingredients, such as NC75 Vita Tech Collagen, NC77 Vita Vinea, NC78 Vita Sculptis, and others, which are often used as raw materials in end-use cosmetics, pharmaceuticals, and other products. It generates maximum revenue from selling ingredients and active ingredients as raw materials to its clients in the cosmetics industry. Geographically, the company generates maximum revenue from its business in Italy.
Contact Information
Website
www.arterrabio.itCorporate Office
- Via Benedetto Brin, 69
- 80142 Naples
- Italy
Corporate Office
- Via Benedetto Brin, 69
- 80142 Naples
- Italy
Arterra Bioscience Stock Performance
As of 20-Nov-2026, Arterra Bioscience’s stock price is $3.10. Its current market cap is $20.2M with 6.51M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.10 | $3.19 | $2.99 - $4.08 | $20.2M | 6.51M | 4.6K | $0.30 |
Arterra Bioscience Financials Summary
As of 30-Jun-2026, Arterra Bioscience has a trailing 12-month revenue of $6.03M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 20,260 | 19,468 | 10,098 | 5,895 |
| Revenue | 6,031 | 5,307 | 4,516 | 3,610 |
| EBITDA | 2,603 | 2,517 | 2,069 | 1,895 |
| Net Income | 1,940 | 2,263 | 1,446 | 1,164 |
| Total Assets | 16,679 | 17,135 | 13,946 | 13,878 |
| Total Debt | 272 | 306 | 371 | 427 |
Arterra Bioscience Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Arterra Bioscience Patents
Arterra Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3897683-A1 | Cosmetic, pharmaceutical and nutraceutical use of an extract derived from cannabis sativa cell cultures | Active | 20-Dec-2018 | ||
| EP-3897683-B1 | Cosmetic, pharmaceutical and nutraceutical use of an extract derived from cannabis sativa cell cultures | Active | 20-Dec-2018 | ||
| ES-2937391-T1 | Cosmetic, pharmaceutical and nutraceutical use of an extract derived from cannabis sativa cell cultures | Active | 20-Dec-2018 | ||
| ES-2937391-T3 | Cosmetic, pharmaceutical and nutraceutical use of an extract derived from cannabis sativa cell cultures | Active | 20-Dec-2018 | ||
| WO-2020127056-A1 | Cosmetic, pharmaceutical and nutraceutical use of an extract derived from cannabis sativa cell cultures | Inactive | 20-Dec-2018 | A61K36/3482 |
Arterra Bioscience Signals
Arterra Bioscience Investments (3)
Arterra Bioscience’s most recent deal was a Joint Venture with Longevity Bioscience. The deal was made on 03-Sep-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Longevity Bioscience | 03-Sep-2024 | Joint Venture | Other Pharmaceuticals and Biotechnology | ||
| ADL Farmaceutici | 25-Jun-2021 | Corporate | Pharmaceuticals | ||
| Vitalab | 01-Jan-2010 | Joint Venture | Other Commercial Products |
Arterra Bioscience ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Arterra Bioscience Exits (1)
Arterra Bioscience’s most recent exit was on 03-Sep-2024 from Longevity Bioscience. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Longevity Bioscience | 03-Sep-2024 | Completed |
|
Arterra Bioscience FAQs
-
When was Arterra Bioscience founded?
Arterra Bioscience was founded in 2004.
-
Where is Arterra Bioscience headquartered?
Arterra Bioscience is headquartered in Naples, Italy.
-
What is the size of Arterra Bioscience?
Arterra Bioscience has 38 total employees.
-
What industry is Arterra Bioscience in?
Arterra Bioscience’s primary industry is Discovery Tools (Healthcare).
-
Is Arterra Bioscience a private or public company?
Arterra Bioscience is a Public company.
-
What is Arterra Bioscience’s stock symbol?
The ticker symbol for Arterra Bioscience is ARBS.
-
What is the current stock price of Arterra Bioscience?
As of 20-Nov-2026 the stock price of Arterra Bioscience is $3.10.
-
What is the current market cap of Arterra Bioscience?
The current market capitalization of Arterra Bioscience is $20.2M.
-
What is Arterra Bioscience’s current revenue?
The trailing twelve month revenue for Arterra Bioscience is $6.03M.
-
What is Arterra Bioscience’s annual earnings per share (EPS)?
Arterra Bioscience’s EPS for 12 months was $0.30.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process